Foresite Capital Opportunity Management V, LLC - KINNATE BIOPHARMA INC ownership

Back to all holdings Add to watchlist

KINNATE BIOPHARMA INC's ticker is KNTE and the CUSIP is 49705R105. A total of 73 filers reported holding KINNATE BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Foresite Capital Opportunity Management V, LLC ownership history of KINNATE BIOPHARMA INC
ValueSharesWeighting
Q3 2022$3,485,000
-5.2%
291,6670.0%10.46%
+12.9%
Q2 2022$3,678,000
+12.0%
291,6670.0%9.27%
+101.6%
Q1 2022$3,284,000
-36.5%
291,6670.0%4.60%
+32.7%
Q4 2021$5,168,000–291,667–3.46%–
 Download
Other shareholders

There were no reported owners of KINNATE BIOPHARMA INC in Q4 2021.

NameSharesValueWeighting ↓
View complete list of KINNATE BIOPHARMA INC shareholders